|
1
|
Wörns MA and Galle PR: Future perspectives
in hepatocellular carcinoma. Dig Liver Dis. 3:S302–S309. 2010.
|
|
2
|
Rampone B, Schiavone B, Martino A, Viviano
C and Confuorto G: Current management strategy of hepatocellular
carcinoma. World J Gastroenterol. 15:3210–3216. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
El-Serag HB and Rudolph KL: Hepatocellular
carcinoma: epidemiology and molecular carcinogenesis.
Gastroenterology. 132:2557–2576. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Rahbari NN, Mehrabi A, Mollberg NM, Müller
SA, Koch M, Büchler MW and Weitz J: Hepatocellular carcinoma:
current management and perspectives for the future. Ann Surg.
253:453–469. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Parkin DM, Bray F, Ferlay J and Pisani P:
Global cancer statistics, 2002. CA Cancer J Clin. 55:74–108. 2005.
View Article : Google Scholar
|
|
6
|
Llovet JM, Burroughs A and Bruix J:
Hepatocellular carcinoma. Lancet. 362:1907–1917. 2003. View Article : Google Scholar
|
|
7
|
Ahn KS, Sethi G and Aggarwal BB: Embelin,
an inhibitor of X chromosome-linked inhibitor-of-apoptosis protein,
blocks nuclear factor-kappaB (NF-kappaB) signaling pathway leading
to suppression of NF-kappaB-regulated antiapoptotic and metastatic
gene products. Mol Pharmacol. 71:209–219. 2007. View Article : Google Scholar
|
|
8
|
Nikolovska-Coleska Z, Xu L, Hu Z, Tomita
Y, Li P, Roller PP, Wang R, Fang X, Guo R, Zhang M, Lippman ME,
Yang D and Wang S: Discovery of embelin as a cell-permeable,
small-molecular weight inhibitor of XIAP through structure-based
computational screening of a traditional herbal medicine
three-dimensional structure database. J Med Chem. 47:2430–2440.
2004. View Article : Google Scholar
|
|
9
|
Joshi R, Kamat JP and Mukherjee T: Free
radical scavenging reactions and antioxidant activity of embelin:
biochemical and pulse radiolytic studies. Chem Biol Interact.
167:125–134. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Sreepriya M and Bali G: Effects of
administration of embelin and curcumin on lipid peroxidation,
hepatic glutathione antioxidant defense and hematopoietic system
during N-nitrosodiethylamine/ phenobarbital-induced
hepatocarcinogenesis in Wistar rats. Mol Cell Biochem. 284:49–55.
2006. View Article : Google Scholar
|
|
11
|
Singh D, Singh R, Singh P and Gupta RS:
Effects of embelin on lipid peroxidation and free radical
scavenging activity against liver damage in rats. Basic Clin
Pharmacol Toxicol. May 26–2009.(Epub ahead of print).
|
|
12
|
Aird KM, Ding X, Baras A, Wei J, Morse MA,
Clay T, Lyerly HK and Devi GR: Trastuzumab signaling in
ErbB2-overexpressing inflammatory breast cancer correlates with
X-linked inhibitor of apoptosis protein expression. Mol Cancer
Ther. 7:38–47. 2008. View Article : Google Scholar
|
|
13
|
Dai Y, Qiao L, Chan KW, Yang M, Ye J, Ma
J, Zou B, Gu Q, Wang J, Pang R, Lan HY and Wong BC: Peroxisome
proliferator-activated receptor-gamma contributes to the inhibitory
effects of Embelin on colon carcinogenesis. Cancer Res.
69:4776–4783. 2009. View Article : Google Scholar
|
|
14
|
Danquah M, Li F, Duke CB III, Miller DD
and Mahato RI: Micellar delivery of bicalutamide and embelin for
treating prostate cancer. Pharm Res. 26:2081–2092. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Mori T, Doi R, Kida A, Nagai K, Kami K,
Ito D, Toyoda E, Kawaguchi Y and Uemoto S: Effect of the XIAP
inhibitor Embelin on TRAIL-induced apoptosis of pancreatic cancer
cells. J Surg Res. 142:281–286. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Xu YZ, Zheng RL, Zhou Y, Peng F, Lin HJ,
Bu Q, Mao YQ, Yu LT, Yang L, Yang SY and Zhao YL: Small molecular
anticancer agent SKLB703 induces apoptosis in human hepatocellular
carcinoma cells via the mitochondrial apoptotic pathway invitro and
inhibits tumor growth invivo. Cancer Lett. 313:44–53. 2011.
View Article : Google Scholar
|
|
17
|
Yang L, Ling Y, Zhang Z, Zhao Q, Tang J,
Ji H and Zhang Y: ZL11n is a novel nitric oxide-releasing
derivative of farnesylthiosalicylic acid that induces apoptosis in
human hepatoma HepG2 cells via MAPK/mitochondrial pathways. Biochem
Biophys Res Commun. 409:752–757. 2011. View Article : Google Scholar
|
|
18
|
Qian H, Yang Y and Wang X: Curcumin
enhanced adriamycin-induced human liver-derived hepatoma G2 cell
death through activation of mitochondria-mediated apoptosis and
autophagy. Eur J Pharm Sci. 43:125–131. 2011. View Article : Google Scholar
|
|
19
|
Zhang ZF, Guo Y, Zhang JB and Wei XH:
Induction of apoptosis by chelerythrine chloride through
mitochondrial pathway and Bcl-2 family proteins in human hepatoma
SMMC-7721 cell. Arch Pharm Res. 34:791–800. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Handayani T, Sakinah S, Nallappan M and
Pihie AH: Regulation of p53-, Bcl-2- and caspase-dependent
signaling pathway in xanthorrhizol-induced apoptosis of HepG2
hepatoma cells. Anticancer Res. 27:965–971. 2007.PubMed/NCBI
|
|
21
|
Kerr JF, Wyllie AH and Currie AR:
Apoptosis: a basic biological phenomenon with wide-ranging
implications in tissue kinetics. Br J Cancer. 26:239–257. 1972.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chiarugi P and Giannoni E: Anoikis: a
necessary death program for anchorage-dependent cells. Biochem
Pharmacol. 76:1352–1364. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yang C, Jo SH, Csernus B, Hyjek E, Liu Y,
Chadburn A and Wang YL: Activation of peroxisome
proliferator-activated receptor gamma contributes to the survival
of T lymphoma cells by affecting cellular metabolism. Am J Pathol.
170:722–732. 2007. View Article : Google Scholar
|
|
24
|
Allensworth JL, Aird KM, Aldrich AJ,
Batinic-Haberle I and Devi GR: XIAP inhibition and generation of
reactive oxygen species enhances TRAIL sensitivity in inflammatory
breast cancer cells. Mol Cancer Ther. June 6–2012.(Epub ahead of
print).
|
|
25
|
Yang CL, Ma YG, Xue YX, Liu YY, Xie H and
Qiu GR: Curcumin induces small cell lung cancer NCI-H446 cell
apoptosis via the reactive oxygen species-mediated mitochondrial
pathway and not the cell death receptor pathway. DNA Cell Biol.
31:139–150. 2012. View Article : Google Scholar
|
|
26
|
Mattson MP and Kroemer G: Mitochondria in
cell death: novel targets for neuroprotection and cardioprotection.
Trends Mol Med. 9:196–205. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Burlacu A: Regulation of apoptosis by
Bcl-2 family proteins. J Cell Mol Med. 7:249–257. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Saito M, Korsmeyer SJ and Schlesinger PH:
BAX-dependent transport of cytochrome c reconstituted in pure
liposomes. Nat Cell Biol. 2:553–555. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Haeberlein SL: Mitochondrial function in
apoptotic neuronal cell death. Neurochem Res. 29:521–530. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Nicholson DW, Ali A, Thornberry NA,
Vaillancourt JP, Ding CK, Gallant M, Gareau Y, Griffin PR, Labelle
M and Lazebnik YA: Identification and inhibition of the ICE/CED-3
protease necessary for mammalian apoptosis. Nature. 376:37–43.
1995. View
Article : Google Scholar : PubMed/NCBI
|
|
31
|
Riedl SJ and Shi Y: Molecular mechanisms
of caspase regulation during apoptosis. Nat Rev Mol Cell Biol.
5:897–907. 2004. View
Article : Google Scholar : PubMed/NCBI
|
